# Defining high-risk pregnancy: Protocol for a systematic scoping review of clinical determinants, complications, and adverse birth outcomes

**Authors:** Xiali Yang, Xin Wee Chen, Philip R. A. Baker

PMC · DOI: 10.1371/journal.pone.0334326 · PLOS One · 2025-10-15

## TL;DR

This paper outlines a protocol for a systematic review to identify clinical factors and complications associated with high-risk pregnancies and their impact on birth outcomes.

## Contribution

The study introduces a systematic scoping review protocol to synthesize regional classification systems and risk factors for high-risk pregnancies.

## Key findings

- The review will identify clinical determinants used to classify high-risk pregnancies.
- It will assess the relationship between high-risk pregnancy status and adverse birth outcomes.
- Findings will be disseminated through peer-reviewed publication and conference presentations.

## Abstract

Accurately identifying clinical determinants within the medical paradigm is essential for evidence-based planning and management of high-risk pregnancies, and for preventing adverse birth outcomes through targeted interventions. However, a systematic synthesis of regional classification systems, risk factors, complications, and adverse birth outcomes associated with high-risk pregnancies remains lacking.

This study protocol aims to systematically identify relevant published research, assess the risks of bias, and summarize the routinely collected clinical determinants/data used in classifying high-risk pregnancy status and the relationship of this status with its complications.

The bibliographic databases of Cochrane Library, Web of Science, CNKI, SCOPUS, and PubMed-MEDLINE will be searched for observational studies without language restrictions. The two-stage screening process will be conducted, involving independent full-text reviews, risk of bias assessments, and data extraction by two reviewers. Narrative synthesis will address selective publication bias using established critical appraisal and evidence evaluation methods. Study selection and reporting will adhere to the PRISMA-P guidelines.

Ethics approval is not required, as this systematic review utilises only published data. The findings will be disseminated through publication in a peer-reviewed journal and presentation at conferences.

PROSPERO database registration (registration number: CRD420251026327).

## Full-text entities

- **Diseases:** stillbirth (MESH:D050497), drug (MESH:D000081015), macrosomia (MESH:D005320), pregnancy complication (MESH:D011248), postnatal depression (MESH:D019052), Fetal death (MESH:D005313), bleeding (MESH:D006470), depression (MESH:D003866), preterm birth (MESH:D047928), postpartum hemorrhage (MESH:D006473), intrauterine death (MESH:D003643), congenital anomalies (MESH:D000013)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12527127/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12527127/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12527127/full.md

---
Source: https://tomesphere.com/paper/PMC12527127